{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T02:50:51Z","timestamp":1784429451725,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012431","name":"Jiangsu Agricultural Science and Technology Independent Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biologicals.2026.101880","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:50:15Z","timestamp":1771833015000},"page":"101880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preparation of poloxamer-based CPV virus-like particle vaccine and its immunological evaluation in mice"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9036-8117","authenticated-orcid":false,"given":"Fei","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8461-8999","authenticated-orcid":false,"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2026.101880_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2020.04.028","article-title":"Poloxamer: a versatile tri-block copolymer for biomedical applications","author":"Zarrintaj","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.biologicals.2026.101880_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","article-title":"Development of a poloxamer analogs\/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin","volume":"337","author":"Qi","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2026.101880_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10837450.2015.1035728","article-title":"Preparation and in vitro\/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis","volume":"21","author":"Saher","year":"2016","journal-title":"Pharmaceut Dev Technol"},{"key":"10.1016\/j.biologicals.2026.101880_bib4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/ani10071134","article-title":"Pathological, bacteriological and virological findings in sudden and unexpected deaths in young dogs","volume":"10","author":"Piegari","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.biologicals.2026.101880_bib5","series-title":"Isolation and identification of canine parvovirus and study on the immunogenicity of CPV-2c virus-like particles [PhD thesis]","author":"Chen","year":"2024"},{"key":"10.1016\/j.biologicals.2026.101880_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2015.07.027","article-title":"Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: a systematic review of controlled clinical trials","volume":"180","author":"Hernandez-Blanco","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2026.101880_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tvjl.2016.11.011","article-title":"Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs","volume":"219","author":"Freisl","year":"2017","journal-title":"Vet J"},{"key":"10.1016\/j.biologicals.2026.101880_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/JVI.06222-11","article-title":"The role of evolutionary intermediates in the host adaption of canine parvovirus","volume":"86","author":"Stucker","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2026.101880_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.rvsc.2012.01.017","article-title":"Immunogenicity of a DNA-launched replicon-based canine parvovirus DNA vaccine expressing VP2 antigen in dogs","volume":"93","author":"Dahiya","year":"2012","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.biologicals.2026.101880_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2018.08.007","article-title":"Use of plant viruses and virus-like particles for the creation of novel vaccines","volume":"145","author":"Balke","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biologicals.2026.101880_bib11","series-title":"Development of thermosensitive injectable hydrogel and its application as NDV DNA vaccine delivery system [PhD thesis]","author":"Gao","year":"2022"},{"key":"10.1016\/j.biologicals.2026.101880_bib12","series-title":"Preparation and immunogenicity Study of porcine parvovirus virus-like particles [PhD thesis]. Sichuan","author":"Song","year":"2017"},{"key":"10.1016\/j.biologicals.2026.101880_bib13","series-title":"China food and Drug Administration. Technical Guidelines for drug research","year":"2005"},{"key":"10.1016\/j.biologicals.2026.101880_bib14","series-title":"Experimental guidance of veterinary microbiology","author":"Yao","year":"2012"},{"key":"10.1016\/j.biologicals.2026.101880_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biologicals.2026.101880_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2004.09.028","article-title":"Sustained release of lidocaine from poloxamer 407 gels","volume":"288","author":"Ricci","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2026.101880_bib17","first-page":"208","article-title":"Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate","volume":"43","author":"Li","year":"2008","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.biologicals.2026.101880_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120002","article-title":"Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia","volume":"591","author":"Ma","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2026.101880_bib19","first-page":"628","article-title":"Preparation and evaluation in vivo of scutellaria them osensitive gel","volume":"33","author":"Song","year":"2008","journal-title":"China J Chin Mater Med"},{"key":"10.1016\/j.biologicals.2026.101880_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","article-title":"Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats","volume":"184","author":"Barichello","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2026.101880_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1015815624334","article-title":"Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice","volume":"9","author":"Johnston","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.biologicals.2026.101880_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/PDT-120003487","article-title":"Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation","volume":"7","author":"Amiji","year":"2002","journal-title":"Pharmaceut Dev Technol"},{"key":"10.1016\/j.biologicals.2026.101880_bib23","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.biomaterials.2009.01.020","article-title":"Injectable chitosan-based hydrogels for cartilage tissue engineering","volume":"30","author":"Jin","year":"2009","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.biologicals.2026.101880_bib24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jps.2600810707","article-title":"Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the ratp","volume":"81","author":"Pec","year":"1992","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.biologicals.2026.101880_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:57:09Z","timestamp":1778198229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105626000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"alternative-id":["S1045105626000084"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101880","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation of poloxamer-based CPV virus-like particle vaccine and its immunological evaluation in mice","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101880"}}